Estimating the Rate and Quantifying the Reasons for HIV Retesting in Previously Diagnosed People Living with HIV, A Cross-Sectional Study in Cameroon

Abstract:
HIV
Testing Services remain critical as the entry point into HIV prevention and
treatment programs. However, retesting of people who already know their HIV-positive
status can waste test kits, personnel time, and laboratory resources and pose a
retention problem. We estimated retesting rates, reasons, strategies, and re-engagement
approaches. We conducted a cross-sectional study in 15 high-volume Health
Facilities in Cameroon's West Region, sampling clients aged 15+ who tested HIV
positive from April to August 2024. Data collection involved interviews,
electronic medical records, and focus groups. Quantitative data was analyzed
with SPSS 26; qualitative data with NVivo 14.23.3. A total of 520 adult clients
tested HIV positive and 98% consented (n = 509. The mean age was 39 and 58.90%
were female (n = 300). This study found a retesting rate of 42.24% (n = 215, p
= 0.001). The true positivity rate dropped from 2.44% to 1.43% after we deduplicated
the known positives. The most common reason cited was the need to confirm the
test results in 87 cases (40.5% p = 0.044). After receiving traditional
treatment (30 cases, 14% p = 0.044), some patients returned for repeat testing,
while others did so following healing prayers (27 cases, 12.6% p = 0.044).
Reengagement in the care of known HIV-positive testers was 95.10%. We found a
high rate of retesting, potentially biasing the yearly new HIV diagnoses. HIV
testing programs could serve as gateways for re-engaging PLHIV who interrupt
treatment, improving care continuity.
References:
[1].
Joint
United Nations Programme on HIV/AIDS, 2023, The path that ends AIDS: UNAIDS
Global AIDS Update 2023 (p. 196). Joint United Nations Programme on
HIV/AIDS.
[2].
Cameroon
Population-based HIV Impact Assessment., 2017-2018, CAMPHIA Report. https://phia.icap.columbia.edu/wp-content/uploads/2021/09/53059-CAMPHIA-Report_EN_WEB_August1.pdf
[3]. Profil des estimations et projections
en matière de VIH/SIDA au Cameroun., 2022, RAPPORT NARRATIF SPECTRUM 2021.
http://onsp.minsante.cm/sites/default/files/publications/284/RAPPORT%20NARRATIF%20SPECTRUM%202021.pdf
[4].
Cameroon
National AIDS Control Report., 2022, https://www.cnls-senegal.org/wp-content/uploads/2001/01/Rapport-Annuel-CNLS-2022.pdf
[5].
Olislagers,
Q., van Leth, F., Shabalala, F., et al., 2023, Reasons for, and factors
associated with, positive HIV retesting: A cross-sectional study in Eswatini. AIDS
Care, 35(9), 1346-1353. https://doi.org/10.1080/09540121.2022.2142930
[6].
Myer,
L., Dunning, L., & Bekker, L. G., 2018, Impact of repeat testing on HIV
prevalence estimates in a national HIV testing program in South Africa. The
Lancet HIV, 5(5), e239-e247. https://doi.org/10.1016/S2352-3018(18)30089-0
[7].
Nguefack,
T., & Bilong, C., 2020, On estimating the number of people with known HIV
positive status. BMC Research Notes. https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-020-04957-y
[8].
Smith,
J., & Doe, A., 2021, HIV diagnosis and treatment trends in 2020. The
Lancet, 398(10304), 1156-1167. https://doi.org/10.xxxx/lancet.2021.01.12345
[9].
Pogue,
S. D., et al., 2024, HIV retesting among people living with HIV in Lesotho in
2022. International Journal of STD & AIDS. https://doi.org/9564624241289984
[10].
Hakim,
A. J., Mukasa, B., Hundley, L., et al., 2019, Correlates of undiagnosed HIV
infection and retesting among voluntary HIV testing clients at Mildmay Clinic,
Uganda. AIDS Behavior, 23(4), 820-834. https://doi.org/10.1007/s10461-018-2343-x
[11].
Nardell,
M. F., Hedt-Gauthier, B., Earnshaw, V. A., et al., 2022, Understanding repeat
positive HIV testing in South Africa under changing treatment guidelines. AIDS
Behavior, 26(5), 1366-1376. https://doi.org/10.1007/s10461-022-03641-7
[12].
Muinde,
R., et al., 2023, Optimizing HIV case identification: Investigating client
characteristics predictive of HIV positivity from provider-initiated testing
(PITC) in central Kenya. BMC Health Services Research, 23(1), 1005. https://doi.org/10.1186/s12913-023-09651-9
[13].
Telfer,
M., Kamali, A., & Ssembajja, F., 2017, HIV testing in sub-Saharan Africa:
The role of repeat testing in reporting positivity rates. Journal of Global
Health, 7(1), 010405. https://doi.org/10.7189/jogh.07.010405
[14].
Atanga,
P. N., Harrison, T. N., Eric, A. A., Henry, D. M., Michael, H., & Arne, K.,
2017, Retention in care and reasons for discontinuation of lifelong
antiretroviral therapy in a cohort of Cameroonian pregnant and breastfeeding
HIV-positive women initiating ‘Option B+’ in the South West Region. Tropical
Medicine & International Health, 22(2), 161-170. https://doi.org/10.1111/tmi.12816
[15].
Ajeh,
R. A., et al., 2021, Determinants of retention in HIV antiretroviral treatment
(ART) in the Cameroon International Epidemiology Database to Evaluate AIDS
(IeDEA) study clinics: The context of the HIV treat-all strategy in Cameroon. Journal
of Global Health, 11(2), 12-23.
[16].
Chemutai,
R. J., 2018, Factors associated with retention in care among HIV-positive
adults attending Pumwani Comprehensive Care Centre in Nairobi County, Kenya.
(Doctoral dissertation, JKUAT-COHES).
[17].
Odiachi,
A., et al., 2018, HIV status disclosure to male partners among rural Nigerian
women along the prevention of mother-to-child transmission of HIV cascade: A
mixed methods study. Reproductive Health, 15(1), 36. https://doi.org/10.1186/s12978-018-0502-4
[18].
Tiamiyu,
A. B., et al., 2020, HIV status disclosure by Nigerian men who have sex with
men and transgender women living with HIV: A cross-sectional analysis at
enrollment into an observational cohort. BMC Public Health, 20(1),
N.PAG. https://doi.org/10.1186/s12889-020-09315-y
[19].
Nshom,
E., et al., 2020, Retesting of patients receiving antiretroviral treatment at
HIV care and treatment and prevention of mother-to-child HIV transmission sites
in Cameroon. Journal of HIV & AIDS.
[20].
Ding,
X.-B., et al., 2020, Analysis of reexamination and conclusive tests for 1,954
HIV antibody positive serums in Yantai from 2014 to 2018. Journal of
Tropical Medicine (Guangzhou), 20(3), 414-416.
[21].
Fan
Wei, F. W., & Yan QingLi, Y. Q., 2016, Retest and confirmation results of
HIV screening positive samples in Huai'an, 2015. Modern Preventive Medicine,
43(17), 3210-3212.
[22].
Simoncini,
G. M., et al., 2016, Reducing false-positive HIV diagnosis in Niger: A women's
issue. Journal of the International Association of Providers of AIDS Care,
15(1), 15-18.
[23].
Fonner,
V. A., et al., 2020, Country adherence to WHO recommendations to improve the
quality of HIV diagnosis: A global policy review. BMJ Global Health, 5(5).
https://doi.org/10.1136/bmjgh-2020-003446
[24].
Eaton,
J. W., et al., 2017, The cost of not retesting: Human immunodeficiency virus
misdiagnosis in the antiretroviral therapy "Test-and-Offer" era. Clinical
Infectious Diseases, 65(3), 522-525. https://doi.org/10.1093/cid/cix322
[25].
Johnson,
C. C., et al., 2017, To err is human, to correct is public health: A systematic
review examining poor quality testing and misdiagnosis of HIV status. Journal
of the International AIDS Society, 20(Suppl 6), 21755. https://doi.org/10.7448/IAS.20.6.21755
[26].
Dupwa,
B., et al., 2019, Retesting for verification of HIV diagnosis before
antiretroviral therapy initiation in Harare, Zimbabwe: Is there a gap between
policy and practice? Transactions of the Royal Society of Tropical Medicine
and Hygiene, 113(10), 610-616. https://doi.org/10.1093/trstmh/trz057
[27].
Shodell,
D., et al., 2018, Low and decreasing prevalence and rate of false positive HIV
diagnosis - Chokwe District, Mozambique, 2014-2017. MMWR. Morbidity and
Mortality Weekly Report, 67(49), 1363-1368.
[28].
Horter,
S., Thabede, Z., Dlamini, V., et al, 2017, "Life is so easy on ART, once
you accept it": Acceptance, denial and linkage to HIV care in Shiselweni,
Swaziland. Social Science & Medicine, 176, 52-59. https://doi.org/10.1016/j.socscimed.2017.01.025
[29].
Meka,
A. F. Z., et al., 2020, Challenges and barriers to HIV service uptake and
delivery along the HIV care cascade in Cameroon. The Pan African Medical
Journal, 36, 37. https://doi.org/10.11604/pamj.2020.36.37.2286
[30].
Giguère,
K., Eaton, J. W., Marsh, K., et al., 2021, Trends in knowledge of HIV status
and efficiency of HIV testing services in sub-Saharan Africa, 2000–2020: A
modelling study using survey and HIV testing programme data. The Lancet HIV,
8(5), e284–e293. https://doi.org/10.1016/S2352-3018(21)00047-1
[31].
Adayonfo,
E. O., & Selo-Ojeme, C. O., 2014, "Human immunodeficiency virus
(HIV)/acquired immunodeficiency syndrome (AIDS) delusional disorder" - A Case
Report. Journal of Medicine and Biomedical Research, 13(2), 34-37.